
On this episode of Don't Be Rash, Andrew Krakowski, MD, spoke with Sheilagh Maguiness, MD, about the FDA's approval of bemotrizinol and what the new sunscreen filter means for pediatric patients.

Sheilagh Maguiness, MD, is a double board-certified Pediatric Dermatologist and the Division Director for Pediatric Dermatology at the University of Minnesota. She has clinical and research interests in vascular birthmarks and is the Director of the UMMCH multidisciplinary Vascular Anomalies Clinic.

On this episode of Don't Be Rash, Andrew Krakowski, MD, spoke with Sheilagh Maguiness, MD, about the FDA's approval of bemotrizinol and what the new sunscreen filter means for pediatric patients.